BANGALORE (Reuters) – Obagi Medical Products Inc, which develops prescription skin care products, said in an amended filing that it will offer up to 6.3 million shares.

The company is selling 800,000 shares and the selling stockholders are selling 5.5 million, it said in a filing with the U.S. Securities and Exchange Commission.